These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
403 related articles for article (PubMed ID: 9600859)
1. BALB/c and C57Bl/6 mice infected with virulent Burkholderia pseudomallei provide contrasting animal models for the acute and chronic forms of human melioidosis. Leakey AK; Ulett GC; Hirst RG Microb Pathog; 1998 May; 24(5):269-75. PubMed ID: 9600859 [TBL] [Abstract][Full Text] [Related]
2. Burkholderia pseudomallei animal and human isolates from Malaysia exhibit different phenotypic characteristics. Lee SH; Chong CE; Lim BS; Chai SJ; Sam KK; Mohamed R; Nathan S Diagn Microbiol Infect Dis; 2007 Jul; 58(3):263-70. PubMed ID: 17350202 [TBL] [Abstract][Full Text] [Related]
3. The innate interferon gamma response of BALB/c and C57BL/6 mice to in vitro Burkholderia pseudomallei infection. Koo GC; Gan YH BMC Immunol; 2006 Aug; 7():19. PubMed ID: 16919160 [TBL] [Abstract][Full Text] [Related]
4. Interaction between Burkholderia pseudomallei and the host immune response: sleeping with the enemy? Gan YH J Infect Dis; 2005 Nov; 192(10):1845-50. PubMed ID: 16235187 [TBL] [Abstract][Full Text] [Related]
5. Burkholderia pseudomallei: animal models of infection. Titball RW; Russell P; Cuccui J; Easton A; Haque A; Atkins T; Sarkar-Tyson M; Harley V; Wren B; Bancroft GJ Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S111-6. PubMed ID: 19121670 [TBL] [Abstract][Full Text] [Related]
6. Virulence of Burkholderia pseudomallei does not correlate with biofilm formation. Taweechaisupapong S; Kaewpa C; Arunyanart C; Kanla P; Homchampa P; Sirisinha S; Proungvitaya T; Wongratanacheewin S Microb Pathog; 2005 Sep; 39(3):77-85. PubMed ID: 16084684 [TBL] [Abstract][Full Text] [Related]
7. A critical role for neutrophils in resistance to experimental infection with Burkholderia pseudomallei. Easton A; Haque A; Chu K; Lukaszewski R; Bancroft GJ J Infect Dis; 2007 Jan; 195(1):99-107. PubMed ID: 17152013 [TBL] [Abstract][Full Text] [Related]
8. Activity of tigecycline in the treatment of acute Burkholderia pseudomallei infection in a murine model. Feterl M; Govan B; Engler C; Norton R; Ketheesan N Int J Antimicrob Agents; 2006 Nov; 28(5):460-4. PubMed ID: 17046208 [TBL] [Abstract][Full Text] [Related]
9. Inflammation patterns induced by different Burkholderia species in mice. Wiersinga WJ; de Vos AF; de Beer R; Wieland CW; Roelofs JJ; Woods DE; van der Poll T Cell Microbiol; 2008 Jan; 10(1):81-7. PubMed ID: 17645551 [TBL] [Abstract][Full Text] [Related]
10. Susceptibility to Burkholderia pseudomallei is associated with host immune responses involving tumor necrosis factor receptor-1 (TNFR1) and TNF receptor-2 (TNFR2). Barnes JL; Williams NL; Ketheesan N FEMS Immunol Med Microbiol; 2008 Apr; 52(3):379-88. PubMed ID: 18294191 [TBL] [Abstract][Full Text] [Related]
12. Phenotypic characteristics and pathogenic ability across distinct morphotypes of Burkholderia pseudomallei DT. Chen YS; Lin HH; Hung CC; Mu JJ; Hsiao YS; Chen YL Microbiol Immunol; 2009 Mar; 53(3):184-9. PubMed ID: 19302529 [TBL] [Abstract][Full Text] [Related]
13. Experimental Persistent Infection of BALB/c Mice with Small-Colony Variants of Burkholderia pseudomallei Leads to Concurrent Upregulation of PD-1 on T Cells and Skewed Th1 and Th17 Responses. See JX; Samudi C; Saeidi A; Menon N; Choh LC; Vadivelu J; Shankar EM PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004503. PubMed ID: 26974441 [TBL] [Abstract][Full Text] [Related]
14. Neutrophils are the predominant cell-type to associate with Burkholderia pseudomallei in a BALB/c mouse model of respiratory melioidosis. Laws TR; Smither SJ; Lukaszewski RA; Atkins HS Microb Pathog; 2011 Dec; 51(6):471-5. PubMed ID: 21798336 [TBL] [Abstract][Full Text] [Related]
15. Urokinase receptor is necessary for bacterial defense against pneumonia-derived septic melioidosis by facilitating phagocytosis. Wiersinga WJ; Kager LM; Hovius JW; van der Windt GJ; de Vos AF; Meijers JC; Roelofs JJ; Dondorp A; Levi M; Day NP; Peacock SJ; van der Poll T J Immunol; 2010 Mar; 184(6):3079-86. PubMed ID: 20142364 [TBL] [Abstract][Full Text] [Related]
16. CD14 impairs host defense against gram-negative sepsis caused by Burkholderia pseudomallei in mice. Wiersinga WJ; de Vos AF; Wieland CW; Leendertse M; Roelofs JJ; van der Poll T J Infect Dis; 2008 Nov; 198(9):1388-97. PubMed ID: 18855560 [TBL] [Abstract][Full Text] [Related]
17. The molecular and cellular basis of pathogenesis in melioidosis: how does Burkholderia pseudomallei cause disease? Lazar Adler NR; Govan B; Cullinane M; Harper M; Adler B; Boyce JD FEMS Microbiol Rev; 2009 Nov; 33(6):1079-99. PubMed ID: 19732156 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the early host immune response to two widely diverse virulent strains of Burkholderia pseudomallei that cause acute or chronic infections in BALB/c mice. Amemiya K; Dankmeyer JL; Fetterer DP; Worsham PL; Welkos SL; Cote CK Microb Pathog; 2015 Sep; 86():53-63. PubMed ID: 26162294 [TBL] [Abstract][Full Text] [Related]
19. Involvement of L-selectin expression in Burkholderia pseudomallei-infected monocytes invading the brain during murine melioidosis. Chen YS; Lin HH; Hsueh PT; Ni WF; Liu PJ; Chen PS; Chang HH; Sun DS; Chen YL Virulence; 2017 Aug; 8(6):751-766. PubMed ID: 27646437 [TBL] [Abstract][Full Text] [Related]
20. Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei. Wongratanacheewin S; Kespichayawattana W; Intachote P; Pichyangkul S; Sermswan RW; Krieg AM; Sirisinha S Infect Immun; 2004 Aug; 72(8):4494-502. PubMed ID: 15271908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]